CPHI & PMEC China 2026: Asia’s Largest Pharma Event Returns to Shanghai

0 comments

CPHI & PMEC China 2026: Asia’s Premier Pharma Event Returns to Shanghai

SHANGHAI, March 2, 2026 – CPHI & PMEC China 2026, Asia’s largest pharmaceutical event, is scheduled to seize place from June 16-18, 2026, at the Shanghai New International Expo Centre (SNIEC). The event builds upon its success in recent years, offering a crucial platform for sourcing, networking, and innovation within the rapidly growing Chinese pharmaceutical market.

A Hub for the Global Pharma Supply Chain

CPHI & PMEC China brings together suppliers and buyers across the entire pharmaceutical supply chain. With over 3,600 exhibitors and attracting more than 110,000 attendees, the event provides unparalleled opportunities for businesses to connect and collaborate. CPHI China serves as a key marketplace for products and solutions powering modern medicine, including APIs, natural extracts, machinery, laboratory instruments, packaging, biotech, and Traditional Chinese Medicine (TCM).

Expanding Zones and Specialized Areas

The 2026 edition will feature expanded zones dedicated to TCM pavilions and next-generation API showcases, highlighting China’s strengths in both traditional and cutting-edge pharmaceutical advancements. New specialized areas will focus on medical aesthetic packaging, frontier technologies, and smart lab spaces, further broadening the event’s scope. Attendees will have access to Asia’s largest concentration of pharmaceutical machinery manufacturers and cutting-edge production technologies.

Networking and Knowledge Sharing

CPHI & PMEC China 2026 will facilitate direct connections between international buyers and leading suppliers through live equipment demonstrations, technical seminars, and networking programs like the Hosted Buyer Matchmaking Program and plant visits. More than 100 conferences and workshops, led by over 700 experts and officials, will provide attendees with access to market intelligence and technical expertise, covering topics from investigational drugs to biotech and machinery developments. CPHI China aims to position participants at the forefront of pharmaceutical innovation.

China’s Growing Pharmaceutical Powerhouse

According to Informa Markets, the growth of CPHI & PMEC China reflects the extraordinary pace of innovation within China’s pharmaceutical industry. Orhan Caglayan, Executive Vice President, Pharma Portfolio, Informa Markets, stated that the event is “a testament to the resilience and future-forward vision of the pharmaceutical industry.” The event has become essential for global products and solutions.

Event Details

Related Posts

Leave a Comment